M

Moderna

Develops mRNA-based medicines for health

Senior Cyber Risk 3rd Party Analyst

Security Governance, Risk & ComplianceConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • At least 5 years of experience in a similar or related position, including experience with standard concepts within cybersecurity risk management, third-party risk management, or governance, risk, and compliance.
  • Experience owning or supporting third-party cybersecurity risk reviews, including assessment analysis, risk disposition, remediation tracking, documentation, reporting, and cybersecurity addendum support during contract negotiations.
  • Sound judgment to identify when risks, control gaps, contractual concerns, or remediation delays require escalation to drive timely decision-making and appropriate risk treatment.
  • Experience working in a GxP-regulated environment.
  • Strong written and verbal communication skills, including the ability to communicate cybersecurity risk concepts and control expectations to technical and non-technical stakeholders.
  • Experience using artificial intelligence to optimize, augment, or streamline risk analysis, documentation, reporting, workflow management, or stakeholder communications.
  • Proven ability to operate in highly matrixed environments and influence without direct authority.

Responsibilities

  • Own the end-to-end third-party cybersecurity risk review process, from intake and assessment scoping through risk analysis, stakeholder follow-up, remediation tracking, risk disposition, and reporting.
  • Review completed third-party cybersecurity assessments to identify control gaps, residual risks, compensating controls, remediation needs, contractual considerations, and recommended risk treatment decisions.
  • Support contract negotiations by reviewing, interpreting, and advising on the cybersecurity addendum and associated cybersecurity control requirements, including requirements related to incident notification, audit rights, vulnerability management, access control, encryption, logging and monitoring, subcontractor security, secure development, business continuity, and artificial-intelligence-enabled services where applicable.
  • Partner with Legal, Privacy, Procurement, business owners, and technical stakeholders to align third-party risk decisions, contract obligations, remediation commitments, and governance expectations.
  • Analyze third-party risk trends across assessments, vendors, services, artificial intelligence capabilities, fourth-party dependencies, data types, and GxP impacts to improve Moderna’s third-party cybersecurity risk posture.
  • Support the use of artificial intelligence, automation, and agentic workflows to improve third-party cybersecurity risk processes by documenting requirements, decision logic, control expectations, evidence needs, escalation points, and human oversight requirements.
  • Perform additional tasks as needed.

Desired Qualifications

  • A four-year degree or equivalent relevant work experience, ideally in information systems, cybersecurity, or risk management.
  • Familiarity with third-party cybersecurity risk frameworks and assessment standards such as NIST Cybersecurity Framework, ISO 27001, CIS Controls, SIG, CAIQ, or similar frameworks.
  • Experience with governance, risk, and compliance, workflow, reporting, and collaboration tools such as OneTrust, ServiceNow, Jira, Power BI, Excel, SharePoint, or similar tools.
  • Strong attention to detail and commitment to data integrity, auditability, consistent documentation, and transparent risk reporting.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs